_id
6915f210bc934aba376b2111
Ticker
RVRC
Name
Revium Recovery Inc
Exchange
PINK
Address
Azrieli Business Center, Herzliya, Israel, 4672561
Country
USA
Sector
Healthcare
Industry
Health Information Services
Currency
USD
Website
https://www.reviumrx.com
Description
Revium Rx. operates as a pre-clinical stage biopharmaceutical company focused on the development of nanoparticle-based therapies in the United States. The company develops lipid-based platforms for a variety of uses including antimicrobial resistance and solid tumors. The company specializes in infectious diseases, including antibiotic-resistant infections, solid tumors and vaccination. The company also develops nano-liposomal particles (NLP) based pharmaceutical candidates. It develops nanoparticles-based formulation of a potent antibiotic; novel adjuvant for cancer therapies: and novel immunization based on liposomal protein-loaded technology. The company was formerly known as Revium Recovery Inc. and changed its name to Revium Rx. in December 2024. Revium Rx. was founded in 1997 and is based in Herzliya, Israel.
Last Close
1.05
Volume
516
Current Price
1.5
Change
5
Last Updated
2026-01-06T10:35:20.836Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
91093648
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-938
Operating Income
938
Interest Expense
-
Pretax Income
-972
Net Income
-972
Eps
-0.016005532776762338
Dividends Per Share
-
Shares Outstanding
60729100
Income Tax Expense
-
EBITDA
-937.5
Operating Margin
-
Total Other Income Expense Net
-1910
Cash
3715000
Short Term Investments
521000
Receivables
-
Inventories
-
Total Current Assets
4470000
Property Plant Equipment
13000
Total Assets
19239000
Payables
189000
Short Term Debt
1000
Long Term Debt
-
Total Liabilities
645000
Equity
18594000
Bs_currency_symbol
-
Depreciation
1000
Change In Working Capital
75000
Cash From Operations
-692000
Capital Expenditures
4000
Cash From Investing
496000
Cash From Financing
-
Net Change In Cash
-196000
Cf_currency_symbol
-
PE
-
PB
0.004899080348499516
ROE
-0.005227492739593417
ROA
-0.0050522376422891
FCF
-696000
Fcf Percent
-
Piotroski FScore
0
Health Score
41
Deep Value Investing Score
5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
6
Net Net Investing Score
2.5
Quality Investing Score
4
Value Investing Score
5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-938
Quarters > 0 > income Statement > operating Income
938
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-972
Quarters > 0 > income Statement > net Income
-972
Quarters > 0 > income Statement > eps
-0.016005532776762338
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
60729
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-937.5
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-1910
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
3715000
Quarters > 0 > balance Sheet > short Term Investments
521000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
4470000
Quarters > 0 > balance Sheet > property Plant Equipment
13000
Quarters > 0 > balance Sheet > total Assets
19239000
Quarters > 0 > balance Sheet > payables
189000
Quarters > 0 > balance Sheet > short Term Debt
1000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
645000
Quarters > 0 > balance Sheet > equity
18594000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-972000
Quarters > 0 > cash Flow > depreciation
1000
Quarters > 0 > cash Flow > change In Working Capital
75000
Quarters > 0 > cash Flow > cash From Operations
-692000
Quarters > 0 > cash Flow > capital Expenditures
4000
Quarters > 0 > cash Flow > cash From Investing
496000
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-196000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.016005532776762338
Quarters > 0 > ratios > PB
0.004899080348499516
Quarters > 0 > ratios > ROE
-0.005227492739593417
Quarters > 0 > ratios > ROA
-0.0050522376422891
Quarters > 0 > ratios > FCF
-696000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
41
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
737
Quarters > 1 > income Statement > operating Income
-737
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-634
Quarters > 1 > income Statement > net Income
-634
Quarters > 1 > income Statement > eps
-0.010439822819410825
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
60729
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-736
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
103
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
3911000
Quarters > 1 > balance Sheet > short Term Investments
1020000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
5201000
Quarters > 1 > balance Sheet > property Plant Equipment
9000
Quarters > 1 > balance Sheet > total Assets
19966000
Quarters > 1 > balance Sheet > payables
137000
Quarters > 1 > balance Sheet > short Term Debt
1000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
554000
Quarters > 1 > balance Sheet > equity
18602999
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-634000
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-49000
Quarters > 1 > cash Flow > cash From Operations
-357000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
1000000
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-86000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.010439822819410825
Quarters > 1 > ratios > PB
0.004896710471252511
Quarters > 1 > ratios > ROE
-0.003408052647855327
Quarters > 1 > ratios > ROA
-0.003175398176900731
Quarters > 1 > ratios > FCF
-357000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-1440000
Quarters > 2 > income Statement > operating Income
1440000
Quarters > 2 > income Statement > interest Expense
115000
Quarters > 2 > income Statement > pretax Income
1325000
Quarters > 2 > income Statement > net Income
1325000
Quarters > 2 > income Statement > eps
0.021818205769556932
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
60729100
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
1440000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-115000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
3268000
Quarters > 2 > balance Sheet > short Term Investments
2011000
Quarters > 2 > balance Sheet > receivables
177000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
5517000
Quarters > 2 > balance Sheet > property Plant Equipment
9000
Quarters > 2 > balance Sheet > total Assets
19152000
Quarters > 2 > balance Sheet > payables
142000
Quarters > 2 > balance Sheet > short Term Debt
1000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
360000
Quarters > 2 > balance Sheet > equity
18792000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
1325000
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
394000
Quarters > 2 > cash Flow > cash From Operations
-609000
Quarters > 2 > cash Flow > capital Expenditures
1000
Quarters > 2 > cash Flow > cash From Investing
-6951000
Quarters > 2 > cash Flow > cash From Financing
-47000
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.021818205769556932
Quarters > 2 > ratios > PB
4.847469667943806
Quarters > 2 > ratios > ROE
7.050872711792253
Quarters > 2 > ratios > ROA
6.918337510442774
Quarters > 2 > ratios > FCF
-610000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
64
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
2000
Quarters > 3 > income Statement > gross Profit
-2000
Quarters > 3 > income Statement > operating Expenses
998000
Quarters > 3 > income Statement > operating Income
-1000000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-974000
Quarters > 3 > income Statement > net Income
-974000
Quarters > 3 > income Statement > eps
-0.018613659957327708
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
52327162
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-972000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
26000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
5655000
Quarters > 3 > balance Sheet > short Term Investments
7000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
5902000
Quarters > 3 > balance Sheet > property Plant Equipment
5000
Quarters > 3 > balance Sheet > total Assets
19461000
Quarters > 3 > balance Sheet > payables
124000
Quarters > 3 > balance Sheet > short Term Debt
1000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
173000
Quarters > 3 > balance Sheet > equity
19288000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-974000
Quarters > 3 > cash Flow > depreciation
2000
Quarters > 3 > cash Flow > change In Working Capital
-75000
Quarters > 3 > cash Flow > cash From Operations
-368000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
5679000
Quarters > 3 > cash Flow > cash From Financing
-4950000
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.018613659957327708
Quarters > 3 > ratios > PB
4.069408077561178
Quarters > 3 > ratios > ROE
-5.0497718788884285
Quarters > 3 > ratios > ROA
-5.004881557987771
Quarters > 3 > ratios > FCF
-368000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
38
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
4000
Annuals > 0 > income Statement > gross Profit
-4000
Annuals > 0 > income Statement > operating Expenses
3538000
Annuals > 0 > income Statement > operating Income
-3542000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-3478000
Annuals > 0 > income Statement > net Income
-3478000
Annuals > 0 > income Statement > eps
-0.05727073182378794
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
60729100
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-3474000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
64000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
3268000
Annuals > 0 > balance Sheet > short Term Investments
2011000
Annuals > 0 > balance Sheet > receivables
177000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
5517000
Annuals > 0 > balance Sheet > property Plant Equipment
9000
Annuals > 0 > balance Sheet > total Assets
19152000
Annuals > 0 > balance Sheet > payables
142000
Annuals > 0 > balance Sheet > short Term Debt
1000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
360000
Annuals > 0 > balance Sheet > equity
18792000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-3478000
Annuals > 0 > cash Flow > depreciation
4000
Annuals > 0 > cash Flow > change In Working Capital
295000
Annuals > 0 > cash Flow > cash From Operations
-1211000
Annuals > 0 > cash Flow > capital Expenditures
3000
Annuals > 0 > cash Flow > cash From Investing
-1274000
Annuals > 0 > cash Flow > cash From Financing
3000
Annuals > 0 > cash Flow > net Change In Cash
-
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.05727073182378794
Annuals > 0 > ratios > PB
17.838688378033204
Annuals > 0 > ratios > ROE
-18.507875691783738
Annuals > 0 > ratios > ROA
-18.15998329156224
Annuals > 0 > ratios > FCF
-1214000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
-
Annuals > 1 > income Statement > cost Of Revenue
2000
Annuals > 1 > income Statement > gross Profit
-2000
Annuals > 1 > income Statement > operating Expenses
677000
Annuals > 1 > income Statement > operating Income
-679000
Annuals > 1 > income Statement > interest Expense
3000
Annuals > 1 > income Statement > pretax Income
-1366000
Annuals > 1 > income Statement > net Income
-683000
Annuals > 1 > income Statement > eps
-0.02326416858544965
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
29358453
Annuals > 1 > income Statement > income Tax Expense
-683000
Annuals > 1 > income Statement > EBITDA
-678000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-687000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
530000
Annuals > 1 > balance Sheet > short Term Investments
4950000
Annuals > 1 > balance Sheet > receivables
111000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
5628000
Annuals > 1 > balance Sheet > property Plant Equipment
2000
Annuals > 1 > balance Sheet > total Assets
5630000
Annuals > 1 > balance Sheet > payables
54000
Annuals > 1 > balance Sheet > short Term Debt
1000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
144000
Annuals > 1 > balance Sheet > equity
5486000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-683000
Annuals > 1 > cash Flow > depreciation
2000
Annuals > 1 > cash Flow > change In Working Capital
7000
Annuals > 1 > cash Flow > cash From Operations
-629000
Annuals > 1 > cash Flow > capital Expenditures
1000
Annuals > 1 > cash Flow > cash From Investing
-10000
Annuals > 1 > cash Flow > cash From Financing
734000
Annuals > 1 > cash Flow > net Change In Cash
104000
Annuals > 1 > cash Flow > currency_symbol
-
Annuals > 1 > ratios > PE
-0.02326416858544965
Annuals > 1 > ratios > PB
29.540404768501638
Annuals > 1 > ratios > ROE
-12.449872402479038
Annuals > 1 > ratios > ROA
-12.131438721136767
Annuals > 1 > ratios > FCF
-630000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
-
Annuals > 2 > income Statement > cost Of Revenue
2000
Annuals > 2 > income Statement > gross Profit
-2000
Annuals > 2 > income Statement > operating Expenses
1126000
Annuals > 2 > income Statement > operating Income
-1128000
Annuals > 2 > income Statement > interest Expense
22000
Annuals > 2 > income Statement > pretax Income
-1213000
Annuals > 2 > income Statement > net Income
-1213000
Annuals > 2 > income Statement > eps
-0.04315056926913216
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
28110869
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-1189000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-85000
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
426000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
11000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
457000
Annuals > 2 > balance Sheet > property Plant Equipment
3000
Annuals > 2 > balance Sheet > total Assets
460000
Annuals > 2 > balance Sheet > payables
50000
Annuals > 2 > balance Sheet > short Term Debt
1000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
70000
Annuals > 2 > balance Sheet > equity
390000
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
-1213000
Annuals > 2 > cash Flow > depreciation
2000
Annuals > 2 > cash Flow > change In Working Capital
36000
Annuals > 2 > cash Flow > cash From Operations
-821000
Annuals > 2 > cash Flow > capital Expenditures
2000
Annuals > 2 > cash Flow > cash From Investing
-2000
Annuals > 2 > cash Flow > cash From Financing
375000
Annuals > 2 > cash Flow > net Change In Cash
-448000
Annuals > 2 > cash Flow > currency_symbol
-
Annuals > 2 > ratios > PE
-0.04315056926913216
Annuals > 2 > ratios > PB
397.876915076923
Annuals > 2 > ratios > ROE
-311.02564102564105
Annuals > 2 > ratios > ROA
-263.69565217391306
Annuals > 2 > ratios > FCF
-823000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
35
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
1785000
Annuals > 3 > income Statement > operating Income
-1785000
Annuals > 3 > income Statement > interest Expense
12000
Annuals > 3 > income Statement > pretax Income
-1800000
Annuals > 3 > income Statement > net Income
-1800000
Annuals > 3 > income Statement > eps
-0.16046613629637024
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
11217320
Annuals > 3 > income Statement > income Tax Expense
-236558
Annuals > 3 > income Statement > EBITDA
-1785000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-15000
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
874000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
24000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
997000
Annuals > 3 > balance Sheet > property Plant Equipment
3000
Annuals > 3 > balance Sheet > total Assets
1000000
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
1000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
64000
Annuals > 3 > balance Sheet > equity
936000
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-1800000
Annuals > 3 > cash Flow > depreciation
236558
Annuals > 3 > cash Flow > change In Working Capital
9000
Annuals > 3 > cash Flow > cash From Operations
-939000
Annuals > 3 > cash Flow > capital Expenditures
1000
Annuals > 3 > cash Flow > cash From Investing
-1000
Annuals > 3 > cash Flow > cash From Financing
470000
Annuals > 3 > cash Flow > net Change In Cash
-470000
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-0.16046613629637024
Annuals > 3 > ratios > PB
66.15342564102563
Annuals > 3 > ratios > ROE
-192.30769230769232
Annuals > 3 > ratios > ROA
-180
Annuals > 3 > ratios > FCF
-940000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
35
Valuation > metrics > PE
-0.016005532776762338
Valuation > metrics > PB
0.004899080348499516
Valuation > final Score
70
Valuation > verdict
99.5% Undervalued
Profitability > metrics > ROE
-0.005227492739593417
Profitability > metrics > ROA
-0.02174496644295302
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.03468860922878348
Risk > metrics > Interest Coverage
27.18840579710145
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
23.526315789473685
Liquidity > metrics > Quick Ratio
23.526315789473685
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
51.52530332056194
Prev Valuations > 2
39.30591922438822
Prev Profitabilities > 0
15
Prev Profitabilities > 1
59
Prev Profitabilities > 2
15
Prev Risks > 0
31
Prev Risks > 1
100
Prev Risks > 2
-1940
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:30:48.392Z
Earnings History > 0 > period
2025-03-31
Earnings History > 0 > report Date
2025-03-31
Earnings History > 0 > date
2025-03-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0104
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-12-31
Earnings History > 1 > report Date
2024-12-31
Earnings History > 1 > date
2024-12-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.0218
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-09-30
Earnings History > 2 > report Date
2024-09-30
Earnings History > 2 > date
2024-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0186
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-06-30
Earnings History > 3 > report Date
2024-06-30
Earnings History > 3 > date
2024-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.0243
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-03-31
Earnings History > 4 > report Date
2024-03-31
Earnings History > 4 > date
2024-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.0859
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2023-12-31
Earnings History > 5 > report Date
2023-12-31
Earnings History > 5 > date
2023-12-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.0033
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-09-30
Earnings History > 6 > report Date
2023-09-30
Earnings History > 6 > date
2023-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-0.0057
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-06-30
Earnings History > 7 > report Date
2023-06-30
Earnings History > 7 > date
2023-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.0066
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-03-31
Earnings History > 8 > report Date
2023-03-31
Earnings History > 8 > date
2023-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-0.0077
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2022-12-31
Earnings History > 9 > report Date
2022-12-31
Earnings History > 9 > date
2022-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-0.0081
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2022-09-30
Earnings History > 10 > report Date
2022-09-30
Earnings History > 10 > date
2022-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-0.0094
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-06-30
Earnings History > 11 > report Date
2022-06-30
Earnings History > 11 > date
2022-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-0.0103
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-03-31
Earnings History > 12 > report Date
2022-03-31
Earnings History > 12 > date
2022-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-0.0152
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2021-12-31
Earnings History > 13 > report Date
2021-12-31
Earnings History > 13 > date
2021-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-0.017
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2021-09-30
Earnings History > 14 > report Date
2021-09-30
Earnings History > 14 > date
2021-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-0.0788
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-06-30
Earnings History > 15 > report Date
2021-06-30
Earnings History > 15 > date
2021-06-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-0.0339
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-03-31
Earnings History > 16 > report Date
2021-03-31
Earnings History > 16 > date
2021-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-0.0523
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2020-12-31
Earnings History > 17 > report Date
2020-12-31
Earnings History > 17 > date
2020-12-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-0.0947
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2020-09-30
Earnings History > 18 > report Date
2020-09-30
Earnings History > 18 > date
2020-09-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
-0.6448
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-06-30
Earnings History > 19 > report Date
2020-06-30
Earnings History > 19 > date
2020-06-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
-0.0868
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-03-31
Earnings History > 20 > report Date
2020-03-31
Earnings History > 20 > date
2020-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
-0.7446
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2019-12-31
Earnings History > 21 > report Date
2019-12-31
Earnings History > 21 > date
2019-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
-
Earnings History > 21 > eps Actual
-0.0211
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2019-09-30
Earnings History > 22 > report Date
2019-09-30
Earnings History > 22 > date
2019-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
-
Earnings History > 22 > eps Actual
0
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-06-30
Earnings History > 23 > report Date
2019-06-30
Earnings History > 23 > date
2019-06-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
-
Earnings History > 23 > eps Actual
0
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-03-31
Earnings History > 24 > report Date
2019-03-31
Earnings History > 24 > date
2019-03-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
-
Earnings History > 24 > eps Actual
-0.032
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2018-12-31
Earnings History > 25 > report Date
2018-12-31
Earnings History > 25 > date
2018-12-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
-
Earnings History > 25 > eps Actual
0
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2018-09-30
Earnings History > 26 > report Date
2018-09-30
Earnings History > 26 > date
2018-09-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
-
Earnings History > 26 > eps Actual
-0.0629
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2018-06-30
Earnings History > 27 > report Date
2018-06-30
Earnings History > 27 > date
2018-06-30
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
-
Earnings History > 27 > eps Actual
0
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-03-31
Earnings History > 28 > report Date
2018-03-31
Earnings History > 28 > date
2018-03-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
-
Earnings History > 28 > eps Actual
0
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2010-12-31
Earnings History > 29 > report Date
2010-12-31
Earnings History > 29 > date
2010-12-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
-
Earnings History > 29 > eps Actual
4.1684
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2010-09-30
Earnings History > 30 > report Date
2010-09-30
Earnings History > 30 > date
2010-09-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
-
Earnings History > 30 > eps Actual
-2.6241
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2010-06-30
Earnings History > 31 > report Date
2010-06-30
Earnings History > 31 > date
2010-06-30
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
-
Earnings History > 31 > eps Actual
-1.0415
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2010-03-31
Earnings History > 32 > report Date
2010-03-31
Earnings History > 32 > date
2010-03-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
-
Earnings History > 32 > eps Actual
-0.0629
Earnings History > 32 > eps Estimate
-
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2009-12-31
Earnings History > 33 > report Date
2009-12-31
Earnings History > 33 > date
2009-12-31
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
-
Earnings History > 33 > eps Actual
-0.1234
Earnings History > 33 > eps Estimate
-
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2009-09-30
Earnings History > 34 > report Date
2009-09-30
Earnings History > 34 > date
2009-09-30
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
-
Earnings History > 34 > eps Actual
-0.0753
Earnings History > 34 > eps Estimate
-
Earnings History > 34 > eps Difference
0
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2009-06-30
Earnings History > 35 > report Date
2009-06-30
Earnings History > 35 > date
2009-06-30
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
-
Earnings History > 35 > eps Actual
-0.9555
Earnings History > 35 > eps Estimate
-
Earnings History > 35 > eps Difference
0
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2009-03-31
Earnings History > 36 > report Date
2009-03-31
Earnings History > 36 > date
2009-03-31
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
-
Earnings History > 36 > eps Actual
-0.6906
Earnings History > 36 > eps Estimate
-
Earnings History > 36 > eps Difference
0
Earnings History > 36 > surprise Percent
-
Revium Rx. operates as a pre-clinical stage biopharmaceutical company focused on the development of nanoparticle-based therapies in the United States. The company develops lipid-based platforms for a variety of uses including antimicrobial resistance and solid tumors. The company specializes in infectious diseases, including antibiotic-resistant infections, solid tumors and vaccination. The company also develops nano-liposomal particles (NLP) based pharmaceutical candidates. It develops nanoparticles-based formulation of a potent antibiotic; novel adjuvant for cancer therapies: and novel immunization based on liposomal protein-loaded technology. The company was formerly known as Revium Recovery Inc. and changed its name to Revium Rx. in December 2024. Revium Rx. was founded in 1997 and is based in Herzliya, Israel.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ARVRC Holding AB (publ)'s (STO:RVRC) 9.3% loss last week hit both individual investors who own 49% as well as institutions simplywall.st
Read more →Earnings call transcript: RevolutionRace Q1 2025 sees strong growth Investing.com
Read more →Showing 2 of 7
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Revium Recovery Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-03-31
EPS Actual
-0.0104
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.